HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N1- (2- (2,3- dihydroxyphenyl)- 5- methyl- 2- oxazoline- 4- carboxamido)- N3- (2,3- dihydroxyphenyl)- 1,3- diaminopropane

has both antioxidant and antineoplastic activities; isolated from Serratia ureilytica; structure in first source

Also Known As:

serranticin

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        N1-(2-(2,3-dihydroxyphenyl)-5-methyl-2-oxazoline-4-carboxamido)-N3-(2,3-dihydroxyphenyl)-1,3-diaminopropane: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - N1-(2-(2,3-dihydroxyphenyl)-5-methyl-2-oxazoline-4-carboxamido)-N3-(2,3-dihydroxyphenyl)-1,3-diaminopropane: 1

Experts

1.	Hsu, Hsiu-Ching: 1 article (06/2011)
2.	Hsu, Ya-Wen: 1 article (06/2011)
3.	Kuo, Yao-Haur: 1 article (06/2011)
4.	Liang, Tzu-Wen: 1 article (06/2011)
5.	Liu, Kao-Cheng: 1 article (06/2011)
6.	Wang, San-Lang: 1 article (06/2011)

Related Diseases

1.	Iron Overload 06/01/2011 - "As such, Serranticin has the potential for use as a deferration agent in various iron overload diseases."